Efficacy and safety of guselkumab in Chinese patients with moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled trialKun Huang, Min Zheng, Xiaohua Tao et al.|Chinese Medical Journal|2025Cited by 0